Skip to content

Palmaz BLUE Transhepatic Biliary Stent on SLALOM .018 System PB2460BSSRecalls & reported problems

Cordis Corporation · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 20705032036303), received between Apr 1, 2019 and Apr 1, 2019 — classified as 1 injury.

The most frequently reported specific device problem is “Fracture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Fracture1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 1, 2019Fracture; Fracture

    AS REPORTED, A PALMAZ BLUE ENDOVASCULAR BALLOON-EXPANDABLE STENT THAT WAS PREVIOUSLY IMPLANTED WAS FOUND TO BE IN TWO PIECES AFTER THE PATIENT CAME BACK WITH A CTA, THE SECOND PIECE HAD EMBOLIZED DISTALLY. THE FLOW TO THE BOWEL WAS OKAY AT THE TIME. THE STENT WAS USED FOR A SMA INTERVENTION.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8472082 ↗

Other CATHETER, BILIARY, DIAGNOSTIC devices

All CATHETER, BILIARY, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page